This article analyzes Cuba's healthcare achievements and its pharmaceutical industry development, suggesting implications for public health systems.
This first of two articles explains how the Cuban Revolution succeeded in building a comprehensive, universal, and free public health system, from the disadvantaged situation of a small Southern country without natural resources and under US sanctions. It then examines the origins and development of the local pharmaceutical and biotechnological industries, as well as the major stakeholders in medical research and their recent scientific achievements. It then presents Cuba’s international cooperation in medical research and exports.
No takes yet. Share an insight, caveat, or question.
Rafael Herrera (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: